Zymeworks
ZYME
172 hedge funds and large institutions have $973M invested in Zymeworks in 2024 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 47 increasing their positions, 61 reducing their positions, and 20 closing their positions.
150% more funds holding in top 10
Funds holding in top 10: 2 → 5 (+3)
106% more call options, than puts
Call options by funds: $547K | Put options by funds: $266K
55% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 20
17% more capital invested
Capital invested by funds: $835M → $973M (+$139M)
6% more funds holding
Funds holding: 163 → 172 (+9)
2.81% more ownership
Funds ownership: 93.7% → 96.52% (+2.8%)
23% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 61
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
+$22.2M |
| 2 |
Blackstone Inc
New York
|
+$7.62M |
| 3 |
Walleye Capital
New York
|
+$6.33M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$4.71M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$4.35M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$12.7M |
| 2 |
VPC
Vestal Point Capital
New York
|
-$6.01M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$5.12M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.11M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$4.18M |
ZYME Hedge Fund Activity: Q4 2024 in Review
172 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Zymeworks (ZYME) for Q4 2024, worth a combined $973M — up 17% from $835M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new ZYME positions and 20 closed out — a net gain of 11 holders — while 47 added to existing stakes and 61 trimmed.
The largest buyer was EcoR1 Capital, adding an estimated $22.2M. The largest seller was Morgan Stanley, cutting an estimated $12.7M.
- 172 institutional investors held Zymeworks (ZYME) as of Q4 2024, up from 163 in Q3 2024.
- Funds reported $973M of Zymeworks stock for Q4 2024, up 17% quarter-over-quarter.
- 31 funds opened new Zymeworks positions in Q4 2024 and 20 closed out, a net change of +11 holders.
- The largest Zymeworks buyer in Q4 2024 was EcoR1 Capital, an estimated $22.2M added.
- The largest Zymeworks seller in Q4 2024 was Morgan Stanley, an estimated $12.7M sold.
Based on aggregated 13F filings for Q4 2024.